News Search Results
Aug 06, 2025, 06:30 ET Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
acceptance of new products, the funding and focus of the types of research by the Company's customers, the impact of the growing number of producers of biotechnology research products and related price competition, general economic conditions, the impact of currency exchange rate fluctuations, and the costs and
More news about: Bio-Techne Corporation
Aug 05, 2025, 22:43 ET From AI to Precision Medicine: Taiwan's Smart Healthcare Innovations Shine at Taiwan Expo USA 2025
screening.imedtac Co., Ltd. presents its AI mmWave monitoring radar, enabling non-contact monitoring of vital physiological data.Hukui Biotechnology Co., Ltd. demonstrates a wireless handheld ultrasound device designed for both human and veterinary applications.AI at the Forefront
More news about: TITA & TAITRA
Aug 05, 2025, 16:30 ET Bio-Techne Announces Exosome Diagnostics Divestiture
acceptance of new products, the funding and focus of the types of research by the Company's customers, the impact of the growing number of producers of biotechnology research products and related price competition, general economic conditions, the impact of currency exchange rate fluctuations, and the costs and
More news about: Bio-Techne Corporation
Aug 05, 2025, 16:01 ET Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update
Aug. 5, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today reported financial results for the second quarter ended June 30,
More news about: Rigel Pharmaceuticals, Inc.
Aug 05, 2025, 16:01 ET HALOZYME RAISES 2025 FINANCIAL GUIDANCE RANGES AND REPORTS STRONG SECOND QUARTER 2025 RESULTS
one major region and across more than 100 global markets, Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical and
More news about: Halozyme Therapeutics, Inc.
Aug 05, 2025, 16:01 ET AMGEN REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Aug 05, 2025, 14:00 ET JAMA Surgery Study Confirms Diagnostic Value of Cizzle Bio's DEX-G2 Blood Test For Early Detection of Gastric Cancer
often diagnosed too late for curative treatment. About Cizzle Bio Cizzle Bio is a Texas-based biotechnology company dedicated to revolutionizing cancer diagnostics by advancing biomarker-based blood tests, starting with early detection of lung and gastric
More news about: Cizzle Bio
Aug 05, 2025, 11:48 ET Rubin and Rudman Adds Hospitality and Retail Veteran Barry Barth as Of Counsel in its Real Estate Group
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
Aug 05, 2025, 11:44 ET Cell Line and Membrane Market to Grow at 12.5% CAGR Through 2030
productivity, reduce costs, and support large-scale manufacturing, especially for biologics and vaccines. Investments by Pharmaceutical and Biotechnology Companies in Drug Development: Pharma and biotech firms are investing in biologics and personalized medicine, increasing the demand for reliable
More news about: BCC Research LLC
Aug 05, 2025, 11:29 ET New Jersey Innovation Institute Appoints Chrissy Buteas and Elisa Charters
also strengthened its role in workforce development by expanding training programs in cutting-edge fields such as AI, advanced manufacturing, and biotechnology, creating hands-on opportunities for students and professionals alike About NJII The New Jersey Innovation Institute (NJII) is a 501(c)(3)
More news about: New Jersey Innovation Institute
Aug 05, 2025, 11:10 ET Electronic Device History Record (eDHR) Software Market Size to Grow USD 642 Million by 2031 at a CAGR of 11.1% | Valuates Reports
pharmaceutical companies continue to adopt eDHR systems to drive efficiency and regulatory success. Tightening global regulations in pharmaceuticals, biotechnology, and life sciences is significantly boosting the demand for eDHR Software. Organizations are under continuous scrutiny to maintain accurate, complete,
More news about: Valuates Reports
Aug 05, 2025, 10:45 ET Cell Culture Market to Reach USD 71.1 Billion by 2032, Says SkyQuest Technology Consulting
Landscapes in Healthcare Red Biotechnology Market - https://www.skyquestt.com/report/red-biotechnology-marketSample Preparation Market -
More news about: SkyQuest Technology
Aug 05, 2025, 10:21 ET With 6.4% CAGR, Extracorporeal CO2 Removal Devices Market to Reach US$184.36 million by 2031 | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 05, 2025, 10:07 ET LexisNexis Recognizes Pivot Bio as One of the World's Ten Most Innovative Biotech Startups
Intellectual Property Solutions as one of the world's ten most innovative biotech startups. The recognition comes from a comprehensive analysis of global biotechnology companies using LexisNexis's proprietary Patent Asset Index, which measures the strength and quality of patent portfolios by combining portfolio
More news about: Pivot Bio, Inc
Aug 05, 2025, 10:01 ET Cardiovascular Echocardiography Market is Expected to Reach US$222.14 Million by 2031 | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 05, 2025, 09:46 ET Future Origins Wins ICIS Innovation Award for Drop-in Replacement Nalo™
energy and raw materials, improved economics, safer performance, and lower environmental impact." Future Origins was founded by industrial biotechnology leader Geno, in partnership with Unilever, Kao, and L'Oréal, to commercialize and manufacture high-volume sustainable ingredients for widely used
More news about: Future Origins
Aug 05, 2025, 09:02 ET Beauty Meets Farming: The Dyson Omega™ Nourishing Collection. Engineered to strengthen hair - for maximum shine
Key features: Nourishes and restores dry, brittle and fragile hair with the Dyson Oli7™ blend.Activated by a biotechnology fermented oil complex to deliver nourishment without weighing down the hair.Enriched with antioxidants and carefully selected ingredients
More news about: Dyson
Aug 05, 2025, 08:30 ET Oncolytics Biotech® Announces Upcoming Annual General Meeting and Second Quarter Financial Results
Meeting as guests but will not be able to vote at the Meeting. About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized
More news about: Oncolytics Biotech® Inc.
Aug 05, 2025, 08:00 ET Ouro Medicines Announces Initiation of OM336 Basket Study in Autoimmune Cytopenias and Granting of U.S. FDA Orphan Drug Designation for OM336 in Autoimmune Hemolytic Anemia (AIHA)
SAN FRANCISCO, Aug. 5, 2025 /PRNewswire/ -- Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic, immune-mediated diseases, today announced the initiation of a multi-national
More news about: Ouro Medicines
Aug 05, 2025, 08:00 ET iNtRON Bio, Demonstrated Toxin-Neutralizing Effect of IMPA™ Phage Engineering Technology in Colorectal Cancer Model and Completed the US Patent Application
-impa-phage-engineering-technology-in-colorectal-cancer-model-and-completed-the-us-patent-application-302521505.html SOURCE iNtRON Biotechnology, Inc.
More news about: iNtRON Biotechnology, Inc.
Aug 05, 2025, 08:00 ET Curis Provides Second Quarter 2025 Business Update
Mass., Aug. 5, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today reported its financial and
More news about: Curis, Inc.
Aug 05, 2025, 06:50 ET Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Small Molecule Oral GLP-1R Agonist, ASC30, in Participants with Obesity or Overweight
patent protection until 2044 without patent extensions. About Ascletis Pharma Inc. Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases.
More news about: Ascletis Pharma Inc.
Aug 05, 2025, 05:12 ET BPC Instruments secures 4.4 MSEK order from a public research organisation in the Philippines
instruments enabling more efficient, reliable, and higher quality research and analysis for industries in renewable bioenergy and environmental biotechnology. The result is not only higher accuracy and precision, but also a significant reduction in time consumption and labor requirement for performing
More news about: BPC Instruments AB
Aug 05, 2025, 05:00 ET Trailhead Biosystems Expands iPSC-Derived Portfolio with TrailBio® Hematopoietic Progenitor Cells
Ohio, Aug. 5, 2025 /PRNewswire/ -- Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing scalable human cell models derived from induced pluripotent stem cells (iPSCs), announces the commercial release of TrailBio®
More news about: Trailhead Biosystems Inc
Aug 05, 2025, 05:00 ET Trailhead Biosystems Expands iPSC-Derived Portfolio with TrailBio® Hematopoietic Progenitor Cells
Ohio, Aug. 5, 2025 /PRNewswire/ -- Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing scalable human cell models derived from induced pluripotent stem cells (iPSCs), announces the commercial release of TrailBio®
More news about: Trailhead Biosystems Inc